
An aid group warns that Congo’s Ebola outbreak is still spreading out of control, a death is reported in a Californian E. coli outbreak, British researchers plan a tool to predict aggressive prostate cancer, stored blood reveals how leukaemia develops and Cambodia widens HPV vaccination for girls.
Congo’s Ebola outbreak is still out of control after six months, aid group warns
Six months after it was declared, the Ebola outbreak in the Democratic Republic of Congo is still spreading out of control, Doctors Without Borders said on Thursday, with confirmed cases now above 11,000 and many infections probably going undetected. The medical charity said help was failing to reach the people who need it most, citing untrained and unpaid staff, ambulances without fuel and a shortage of surveillance teams and supplies, and urged the government and UN agencies to act.
British epidemiologist Neil Ferguson of Imperial College London said only about half of cases were likely being found, so transmission could still be under way a year from now and the outbreak might exceed the 2014-2016 epidemic in West Africa. The World Health Organization said insecurity had become one of the biggest obstacles, after an assault on a North Kivu town last week left 66 civilians dead, three of them health workers, and caused more than 1,000 contacts to be lost to follow-up.
This outbreak, which began in mid-May, is driven by the rare Bundibugyo species, against which no vaccine or medicine has yet been approved, and it now ranks as the second worst on record. The species takes its name from a town in western Uganda where it was first discovered, and it had previously caused outbreaks in 2007 and 2012. Scientists have described the current epidemic as the fastest-growing Ebola outbreak ever recorded, and health workers have repeatedly protested over unpaid wages.
One person dies in an E. coli outbreak linked to a California pumpkin farm
One person has died in an outbreak of Shiga toxin-producing E. coli that health officials in San Luis Obispo County, California, have linked to visits to Brookshire Farms. The county has confirmed five cases, and a further 10 people who visited the farm between 16 and 26 October and then fell ill are being treated as suspected cases. Officials have not disclosed the age or identity of the person who died and said the family had agreed to the announcement.
Laboratory checks of the farm’s water, food and other material detected some bacteria, among them different E. coli strains, but not the one behind the outbreak. Those who fell ill had possible exposure to corn cups, pumpkins, hay and water that was not meant for drinking, but investigators could not identify a single source. No farm animals or petting zoos were open to visitors, and the county health officer said the risk had now passed.
Symptoms of this kind of infection, such as cramps, severe stomach pain and bloody diarrhoea, usually begin three to 10 days after exposure. Children under 10 face the greatest risk of complications, including haemolytic uraemic syndrome, a condition that destroys red blood cells and can cause kidney failure. The syndrome was first defined in 1955, and although most affected children recover without lasting harm, some suffer serious and sometimes life-threatening complications.
UK study aims to build a computer model that predicts aggressive prostate cancer
Researchers in Britain have launched a £1.4 million project to build a computer model that could tell doctors at diagnosis which prostate cancers are likely to become dangerous. The study, called Reimagine, will analyse medical information from more than 1,000 men with the disease and link it to NHS records showing how their cancer progressed, comparing samples from slow-growing tumours with those from more aggressive forms. The trial is due to start on 10 December.
The project is led by Professor Mieke Van Hemelrijck of King’s College London, with researchers from University College London, Imperial College London and Radboud University, and is funded by Prostate Cancer UK and the John Black Charitable Foundation. The charity says current tests cannot reliably forecast how a man’s cancer will behave, leaving tens of thousands of men each year at risk of incontinence and erection problems from biopsies or treatment they did not need.
Prostate cancer often causes no symptoms at first because it usually grows on the outer part of the gland, away from the urethra, and is usually detected through blood tests that measure prostate-specific antigen, or PSA. Cases are given a stage from 1 to 4 based on the Gleason score, PSA levels and imaging, but these measures cannot yet say for certain which tumours will remain harmless over time.
Stored blood samples trace leukaemia mutations back decades before diagnosis
Scientists at the University of Cambridge and UCL have reconstructed how acute myeloid leukaemia develops in the decades before it is diagnosed, finding that in two-thirds of cases the first cancer-causing mutation appeared before the age of 20. The team used yearly blood samples from a large ovarian cancer screening trial, studying 47 women who later developed the disease and 46 who did not, with some samples taken 15 years before diagnosis.
The study, published in Nature, found that cells with that first mutation grew slowly for decades, while each further mutation raised their growth rate two- to three-fold, until cells with four such mutations doubled in a matter of weeks. Because the growth proved so predictable, the researchers said a few samples taken today could show how large a clone might become, opening a possible window to prevent the cancer.
Acute myeloid leukaemia is a cancer of the myeloid line of blood cells in which abnormal cells build up in the bone marrow and crowd out the production of healthy blood cells. It mostly affects older adults and is aggressive, with around 2,700 people diagnosed in the UK each year and only about one in six surviving for five years. Many healthy older people carry related mutations, but only a few go on to develop it.
Cambodia launches a nationwide HPV catch-up campaign for adolescent girls
Cambodia has begun a nationwide vaccination campaign against human papillomavirus, offering free doses to all girls aged 13 to 14 and catch-up shots to girls aged 10 to 12 who missed their routine vaccination between 2023 and 2025. The campaign will be carried out in two phases between November and December through schools, community centres and local clinics, alongside the routine vaccination of nine-year-old girls that began in 2023.
Health Minister Chheang Ra said every girl deserved protection from cervical cancer, which is the second most common cancer among Cambodian women. The World Health Organization representative in the country said widening access up to age 14 would speed progress towards eliminating the disease. Gavi, the Vaccine Alliance, is providing more than three million US dollars for the campaign, which aims to reach more than 700,000 girls in schools and communities.
Nearly all cases of cervical cancer are caused by persistent infection with high-risk strains of HPV, which is why vaccination is seen as one of the most effective ways to prevent it. The first HPV vaccines became available in 2006, and many countries now use a single-dose schedule after studies showed one dose gives protection similar to two. An estimated 13 deaths are averted for every 1,000 children vaccinated.